Prosecution Insights
Last updated: April 19, 2026

Teva Pharmaceuticals International GmbH

6 pending office actions

Portfolio Summary

6
Total Pending OAs
4
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18233390 SOLID STATE FORMS OF LUMATEPERONE DITOSYLATE SALT MOORE, SUSANNA 1624 Non-Final OA Aug 14, 2023
18037973 RATE-LIMITED SYRINGE LANGE, ERIC A 3783 Non-Final OA May 19, 2023
18023408 VIAL ADAPTOR WITH VALVE WENG, KAI H 3781 Final Rejection Feb 27, 2023
18064437 INJECTION SPRING FOR AGED PREFILLED SYRINGE AND AUTO INJECTOR SCHMIDT, EMILY LOUISE 3783 Final Rejection Dec 12, 2022
18007821 SOLID STATE FORMS OF ENSARTINIB AND ENSARTINIB SALTS BRAUN, MADELINE E 1624 Final Rejection Dec 02, 2022
17278123 INJECTION SPRING FOR AGED PREFILLED SYRINGE AND AUTO INJECTOR SCHMIDT, EMILY LOUISE 3783 Final Rejection Mar 19, 2021

Managing Teva Pharmaceuticals International GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month